Anterior pituitary morphology and hormone production during sustained critical illness in a rabbit model.

Prolonged critical illness is hallmarked by striking alterations in the somatrope, thyrotrope, and lactotrope axes, the severity of which is associated with the risk of morbidity and mortality. The exact role of the pituitary gland in these alterations is unknown. We studied the impact of sustained critical illness on pituitary morphology and hormone production in a standardized rabbit model of prolonged (7 days) burn injury-induced critical illness. In healthy and prolonged critically ill rabbits, we determined pituitary weight, size, morphology and orientation of the somatrope, lactotrope and thyrotrope cells and the pituitary expression of GH, PRL, and TSH at gene and protein level. The weight of the pituitary gland was unaltered by 7 days of critical illness. Also, spatial orientation and morphology of the GH, PRL, and TSH producing cells remained normal. In prolonged critically ill rabbits GH mRNA levels were higher and PRL mRNA levels were lower than in healthy controls, whereas TSH mRNA was not affected. The sizes of GH, PRL, or TSH producing cells and the pituitary content of GH, PRL, and TSH proteins were unaltered. In conclusion, in this rabbit model of prolonged critical illness, the morphology of the pituitary gland and the pituitary GH, PRL, and TSH content was normal. The alterations in pituitary hormone mRNA levels with sustained critical illness are compatible with altered hypothalamic and peripheral regulation of pituitary hormone release as previously suggested indirectly by responses to exogenous releasing factors.

[1]  R. MacLaren,et al.  Gastrointestinal hormone concentrations associated with gastric feeding in critically ill patients. , 2012, JPEN. Journal of parenteral and enteral nutrition.

[2]  G. Van den Berghe,et al.  Contribution of nutritional deficit to the pathogenesis of the nonthyroidal illness syndrome in critical illness: a rabbit model study. , 2012, Endocrinology.

[3]  M. Tschöp,et al.  Ghrelin acylation and metabolic control , 2011, Peptides.

[4]  E. Fliers,et al.  Acute Inflammation Increases Pituitary and Hypothalamic Glycoprotein Hormone Subunit B5 mRNA Expression in Association with Decreased Thyrotrophin Receptor mRNA Expression in Mice , 2011, Journal of neuroendocrinology.

[5]  G. Van den Berghe,et al.  Changes in the central component of the hypothalamus-pituitary-thyroid axis in a rabbit model of prolonged critical illness , 2009, Critical care.

[6]  K. Sjögren,et al.  The role of liver-derived insulin-like growth factor-I. , 2009, Endocrine reviews.

[7]  D. Witcher,et al.  Ghrelin octanoylation mediated by an orphan lipid transferase , 2008, Proceedings of the National Academy of Sciences.

[8]  P. Barnett,et al.  Somatostatin and somatostatin receptor physiology , 2003, Endocrine.

[9]  G. Van den Berghe,et al.  The dynamic neuroendocrine response to critical illness. , 2006, Endocrinology and metabolism clinics of North America.

[10]  E. Fliers,et al.  Functional neuroanatomy of thyroid hormone feedback in the human hypothalamus and pituitary gland , 2006, Molecular and Cellular Endocrinology.

[11]  S. Brett,et al.  Changes in appetite related gut hormones in intensive care unit patients: a pilot cohort study , 2005, Critical care.

[12]  G. Van den Berghe,et al.  Changes within the GH/IGF-I/IGFBP axis in critical illness. , 2006, Critical care clinics.

[13]  F. Casanueva,et al.  Low plasma ghrelin level in gastrectomized patients is accompanied by enhanced sensitivity to the ghrelin-induced growth hormone release. , 2005, The Journal of clinical endocrinology and metabolism.

[14]  Ping Wang,et al.  Upregulation of cardiovascular ghrelin receptor occurs in the hyperdynamic phase of sepsis. , 2004, American journal of physiology. Heart and circulatory physiology.

[15]  G. Van den Berghe,et al.  Metabolic, endocrine, and immune effects of stress hyperglycemia in a rabbit model of prolonged critical illness. , 2003, Endocrinology.

[16]  F. Casanueva,et al.  Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. , 2003, The Journal of clinical endocrinology and metabolism.

[17]  C. Bowers,et al.  Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. , 2003, Endocrinology.

[18]  G. Van den Berghe,et al.  The combined administration of GH‐releasing peptide‐2 (GHRP‐2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP‐2 alone , 2002, Clinical endocrinology.

[19]  G. Van den Berghe,et al.  A novel in vivo rabbit model of hypercatabolic critical illness reveals a biphasic neuroendocrine stress response. , 2002, Endocrinology.

[20]  N. Ben-Jonathan,et al.  Dopamine as a prolactin (PRL) inhibitor. , 2001, Endocrine reviews.

[21]  G. Van den Berghe,et al.  Five-day pulsatile gonadotropin-releasing hormone administration unveils combined hypothalamic-pituitary-gonadal defects underlying profound hypoandrogenism in men with prolonged critical illness. , 2001, The Journal of clinical endocrinology and metabolism.

[22]  R. Borski,et al.  Insulin-like growth factor I disparately regulates prolactin and growth hormone synthesis and secretion: studies using the teleost pituitary model. , 2000, Endocrinology.

[23]  G. Nagy,et al.  Prolactin: structure, function, and regulation of secretion. , 2000, Physiological reviews.

[24]  G. Van den Berghe,et al.  A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness. , 2000, The Journal of clinical endocrinology and metabolism.

[25]  G. Van den Berghe,et al.  Reactivation of pituitary hormone release and metabolic improvement by infusion of growth hormone-releasing peptide and thyrotropin-releasing hormone in patients with protracted critical illness. , 1999, The Journal of clinical endocrinology and metabolism.

[26]  L. Ştefăneanu,et al.  Somatotroph and lactotroph changes in the adenohypophyses of mice with disrupted insulin-like growth factor I gene. , 1999, Endocrinology.

[27]  G. Van den Berghe,et al.  Growth hormone-releasing peptide-2 infusion synchronizes growth hormone, thyrotrophin and prolactin release in prolonged critical illness. , 1999, European journal of endocrinology.

[28]  E. Fliers,et al.  Decreased hypothalamic thyrotropin-releasing hormone gene expression in patients with nonthyroidal illness. , 1997, The Journal of clinical endocrinology and metabolism.

[29]  G. Van den Berghe,et al.  The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion. , 1997, The Journal of clinical endocrinology and metabolism.

[30]  F. Zegher,et al.  Dopamine and the sick euthyroid syndrome in critical illness , 1994, Clinical endocrinology.

[31]  F. Zegher,et al.  Luteinizing hormone secretion and hypoandrogenaemia in critically ill men: effect of dopamine , 1994, Clinical endocrinology.

[32]  F. Wondisford,et al.  A detailed functional and structural analysis of a major thyroid hormone inhibitory element in the human thyrotropin beta-subunit gene. , 1991, The Journal of biological chemistry.

[33]  J. Miell,et al.  Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin–like growth factor‐I , 1991, Clinical endocrinology.

[34]  K. Prank,et al.  Hypothalamic regulation of pulsatile thyrotopin secretion. , 1991, The Journal of clinical endocrinology and metabolism.

[35]  P. Parte,et al.  Diurnal variations and temporal coupling of bioactive and immunoactive luteinizing hormone, prolactin, testosterone and 17-beta-estradiol in adult men. , 1991, Hormone research.

[36]  S. Lamberts,et al.  Regulation of prolactin secretion at the level of the lactotroph. , 1990, Physiological reviews.

[37]  F. Wondisford,et al.  Pre-translational and post-translational regulation of TSH synthesis in normal and neoplastic thyrotrophs. , 1989, Hormone research.

[38]  M. Greer,et al.  There is a nyctohemeral rhythm of type II iodothyronine 5'-deiodinase activity in rat anterior pituitary. , 1988, Endocrinology.

[39]  S. Melmed,et al.  Insulinlike growth factor I regulation of growth hormone gene transcription in primary rat pituitary cells. , 1987, The Journal of clinical investigation.

[40]  N. Ling,et al.  The interrelationship of growth hormone (GH)-releasing factor and somatostatin in generation of the ultradian rhythm of GH secretion. , 1984, Endocrinology.

[41]  C. Benedict,et al.  Plasma noradrenaline and adrenaline concentrations and dopamine-beta-hydroxylase activity in patients with shock due to septicaemia, trauma and haemorrhage. , 1978, The Quarterly journal of medicine.

[42]  R. Guillemin,et al.  TRF and thyroid hormones on prolactin secretion by rat anterior pituitary cells in vitro. , 1973, Endocrinology.